NCT00734773: Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL |
|
|
| Withdrawn | 1 | 0 | US | Rituximab, Rituxan, Cytarabine, Cytosar-U, Ara-c, Methotrexate, MTX, Rheumatrex, Trexall, Motexafin gadolinium, MGd, Procarbazine hydrochloride, Matulane, Vincristine sulfate, Vincasar PFS, Radiation therapy, Whole Brain Radiation Therapy (WBRT) | Northwestern University, Pharmacyclics LLC. | Brain and Central Nervous System Tumors, Lymphoma, Neurotoxicity | | | | |
